ClinicalTrials.Veeva

Menu

The DIPOD Study (Diagnosis Improvement of Pneumonia by Organ Dysfunction)

C

Centre Chirurgical Marie Lannelongue

Status

Completed

Conditions

Pneumonia, Ventilator-Associated

Study type

Observational

Funder types

Other

Identifiers

NCT02683122
P15-37816003/2015-NI

Details and patient eligibility

About

The place of analysis of organ dysfunction in relation to the diagnosis of nosocomial pneumonia in intensive care is not yet defined.

Full description

New onset of pulmonary infiltrates, fever, and an increase in white blood cell (WBC) count accompanied by purulent tracheal secretions are clinically indicative of hospital-associated pneumonia (HAP). The low specificity and sensibility of diagnostic tests for HAP, however, tends to result in an extremely high incidence of missed diagnoses and may lay to high mortality.

The place of analysis of organ dysfunction in relation to the diagnosis of nosocomial pneumonia in intensive care is not yet defined, because early organ dysfunction may be the first symptoms noted by clinicians.

Enrollment

298 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients after cardiac/thoracic surgery with suspicion of HAP defined by the presence of the following criteria:

  • new onset of pulmonary infiltrates,
  • fever >38,3°C,
  • increase in white blood cell (WBC) count
  • purulent tracheal secretions
  • but also:
  • increased use of catecholamine,
  • need of volemic expansion,
  • depletion inability,
  • confusion,
  • hepatic perturbation with increased gamma-glutamyl transpeptidase (GGT)>2N or alkaline phosphatase (ALP) >1.5 N, or bilirubin >1.5N, or aminotransferase (AST or ALT>2 N).

Exclusion criteria

  • child,
  • pregnancy,
  • end of life.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems